Prenatal Care Practice Questions

Q: What is the best marker for gestational age in the second trimester?

Biparietal diameter. **Explanation:** The determination of gestational age (GA) via ultrasound relies on different parameters depending on the trimester. In the **second trimester (13–26 weeks)**, the **Biparietal Diameter (BPD)** is considered the most classic and reliable single marker for dating, with an accuracy of ±7–10 days. It is measured at the level of the thalami and cavum septum pellucidum. While Head Circumference (HC) is also highly accurate, BPD remains the traditional gold standard for this specific period in most standardized examinations. **Analysis of Options:** * **B. Head Circumference (HC):** While HC is less affected by head shape (like dolichocephaly or brachycephaly) than BPD, BPD is historically the preferred answer for "best marker" in the second trimester for exam purposes. * **C. Crown-Rump Length (CRL):** This is the **most accurate** method for dating a pregnancy overall, but it is only used in the **first trimester** (up to 13 weeks 6 days). After this, the fetus begins to curl, making CRL measurements inaccurate. * **D. Femur Length (FL):** This is a reliable marker used in the second and third trimesters, but it is generally considered slightly less accurate than head measurements for dating unless there is cranial pathology. **High-Yield Clinical Pearls for NEET-PG:** * **Best overall predictor of GA:** Crown-Rump Length (CRL) in the 1st Trimester (Accuracy: ±3–5 days). * **Best marker in 3rd Trimester:** Femur Length (FL) is often preferred as BPD accuracy falls to ±3 weeks due to biological variation. * **Composite GA:** Using a combination of BPD, HC, AC (Abdominal Circumference), and FL is more accurate than any single parameter. * **Abdominal Circumference:** The best predictor of **fetal weight** and growth (IUGR/Macrosomia), but the poorest predictor of gestational age.

Q: Which is the least likely physiological change in pregnancy?

Increase in peripheral vascular resistance. **Explanation:** In pregnancy, the cardiovascular system undergoes significant adaptation to meet the metabolic demands of the fetus. The correct answer is **D (Increase in peripheral vascular resistance)** because systemic vascular resistance (SVR) actually **decreases** significantly during pregnancy. **Why D is correct:** The decrease in SVR is one of the earliest physiological changes, driven by high levels of **progesterone** (a smooth muscle relaxant) and increased production of local vasodilators like **nitric oxide and prostaglandins**. This drop in resistance is necessary to accommodate the massive increase in blood volume and ensures adequate perfusion to the uteroplacental unit. **Why other options are incorrect:** * **A. Increase in intravascular volume:** Plasma volume increases by 40–50%, starting as early as 6 weeks. This is a hallmark of normal pregnancy. * **B. Increase in cardiac output:** Cardiac output increases by 30–50%. It is the product of Heart Rate × Stroke Volume, both of which increase during pregnancy. * **C. Increase in stroke volume:** Stroke volume increases early in pregnancy (peaking at 20–24 weeks) due to increased blood volume and decreased afterload (SVR). **NEET-PG High-Yield Pearls:** * **Blood Pressure:** Despite increased cardiac output, BP typically **decreases** in the first and second trimesters (due to decreased SVR), reaching its nadir at 24 weeks before returning to pre-pregnancy levels at term. * **Heart Sounds:** A physiological S3 and a systolic ejection murmur (grade 1 or 2) are considered normal in pregnancy. A diastolic murmur is **always** pathological. * **Positioning:** Cardiac output is highest in the **left lateral position** because it relieves the compression of the inferior vena cava by the gravid uterus (preventing Supine Hypotension Syndrome).

Q: At what gestational age is the yolk sac earliest seen?

5.5 weeks. **Explanation:** The appearance of gestational structures on ultrasound follows a predictable chronological sequence, which is a high-yield topic for NEET-PG. 1. **Why 5.5 weeks is correct:** The **yolk sac** is the first structure to appear within the gestational sac and is the definitive sonographic sign of an intrauterine pregnancy. Using a Transvaginal Scan (TVS), the yolk sac typically becomes visible at **5.5 weeks** of gestation (when the Mean Sac Diameter is approximately 8 mm). It plays a crucial role in nutrient transfer and hematopoiesis before the placenta is fully functional. 2. **Why the other options are incorrect:** * **7.5 weeks:** By this stage, the embryo is clearly visible with distinct cardiac activity (which starts at ~6 weeks). The yolk sac is already well-established. * **10 weeks:** At this point, the yolk sac begins to degenerate as the placenta takes over nutritional functions. It typically disappears by the end of the first trimester (12 weeks). * **12.5 weeks:** The yolk sac is usually no longer visible on ultrasound by this time, as it has been incorporated into the gut tube or has regressed. **Clinical Pearls for NEET-PG:** * **Order of appearance (TVS):** Gestational Sac (4.5–5 weeks) → Yolk Sac (5.5 weeks) → Fetal Pole/Embryo with Heartbeat (6 weeks). * **Rule of 10s (Abdominal Scan):** Structures are generally seen 1 week later on Transabdominal Scan (TAS) compared to TVS. * **Discriminatory Zone:** If the β-hCG is >1500–2000 mIU/ml (TVS), a gestational sac should be visible. * **Abnormal Yolk Sac:** A yolk sac diameter **>6 mm** or a calcified yolk sac is often associated with an abnormal pregnancy outcome or fetal demise.

Q: Which of the following conditions is associated with increased AFP levels?

Congenital nephrosis. **Explanation:** Alpha-fetoprotein (AFP) is a glycoprotein synthesized by the fetal yolk sac and liver. It is excreted into the fetal urine and subsequently enters the maternal circulation. Levels of Maternal Serum AFP (MSAFP) are a crucial screening tool between 15–20 weeks of gestation. **Why Congenital Nephrosis is Correct:** In **Congenital Nephrosis (Finnish type)**, there is a defect in the glomerular filtration barrier (specifically the protein nephrin). This leads to massive proteinuria in utero. Since AFP is a protein, it leaks into the amniotic fluid in large quantities and subsequently into the maternal serum, resulting in **markedly elevated AFP levels**. **Analysis of Incorrect Options:** * **Down’s Syndrome (Trisomy 21):** This is associated with **decreased** AFP levels (along with decreased Estriol and increased hCG/Inhibin-A). * **Molar Pregnancy:** Gestational trophoblastic disease is associated with **decreased** AFP levels because there is no functional fetal liver or yolk sac to produce it. * **Overestimated Gestational Age:** AFP levels rise naturally as pregnancy progresses. If the gestational age is overestimated (e.g., the patient is actually 14 weeks but thought to be 18 weeks), the AFP will appear **falsely low** for the perceived date. Conversely, *underestimated* age causes high AFP. **High-Yield Clinical Pearls for NEET-PG:** * **Most common cause of elevated MSAFP:** Underestimated gestational age (dating error). * **Other causes of increased AFP:** Neural Tube Defects (Anencephaly, Spina Bifida), Abdominal wall defects (Omphalocele, Gastroschisis), Multiple gestations, and Fetal demise. * **Mnemonic for Low AFP:** "**D**own **M**e **Q**uickly" (**D**own syndrome, **M**olar pregnancy, **Q**uestionable/Overestimated dates).

Q: What is the definition of full-term pregnancy in terms of gestational weeks?

39 completed to 40 6/7 weeks. **Explanation:** The definition of a "term" pregnancy was refined by the ACOG and SMFM to reflect the differences in neonatal outcomes across the 37–42 week window. The correct answer is **B (39 0/7 to 40 6/7 weeks)**, which is now formally defined as **Full Term**. Research indicates that neonates born during this specific window have the lowest risk of respiratory distress, sepsis, and NICU admissions compared to those born earlier. **Analysis of Options:** * **Option A (37 0/7 to 38 6/7 weeks):** This is defined as **Early Term**. While technically "term" in older classifications, these infants face higher risks of morbidity (e.g., transient tachypnea of the newborn) compared to full-term infants. * **Option C (41 0/7 to 41 6/7 weeks):** This is defined as **Late Term**. At this stage, there is an increased risk of meconium aspiration and placental insufficiency. * **Option D (42 0/7 weeks and beyond):** This is defined as **Post-term**. These pregnancies require close monitoring or induction due to the significantly increased risk of stillbirth and dysmaturity syndrome. **NEET-PG High-Yield Pearls:** 1. **Preterm:** Before 37 0/7 weeks. 2. **Full Term:** 39 0/7 to 40 6/7 weeks (The "Sweet Spot" for delivery). 3. **Naegele’s Rule:** Used to calculate the Expected Date of Delivery (EDD) = LMP + 7 days - 3 months + 1 year. 4. **Clinical Significance:** Elective inductions or Cesarean sections should not be performed before 39 weeks unless medically indicated, to ensure optimal fetal lung maturity.

Q: Which of the following is NOT a criterion for fetal growth assessment?

Maternal weight gain. **Explanation:** The assessment of fetal growth relies on parameters that directly measure the fetus or the uterine size reflecting fetal volume. **Maternal weight gain** is not a reliable criterion for fetal growth because it is influenced by numerous extrinsic and maternal factors, including maternal obesity, edema (preeclampsia), polyhydramnios, and nutritional status. While poor weight gain may raise suspicion, it lacks the specificity and sensitivity required to diagnose fetal growth restriction (FGR). **Analysis of Options:** * **Height of the Uterus (Symphysio-fundal height):** This is the primary clinical screening tool. After 24 weeks, the SFH in centimeters typically corresponds to the gestational age in weeks. A discrepancy of >3 cm suggests growth abnormalities or fluid volume issues. * **Biparietal Diameter (BPD):** An essential USG biometric parameter. While more accurate for dating in the second trimester, it helps assess head growth and is used to calculate the Estimated Fetal Weight (EFW). * **Abdominal Circumference (AC):** This is the **most sensitive** single biometric parameter for assessing fetal growth and nutrition. Since the liver is the first organ to show effects of malnutrition (depletion of glycogen stores), AC is the first parameter to lag in asymmetric FGR. **High-Yield Clinical Pearls for NEET-PG:** * **Best USG parameter for dating (1st Trimester):** Crown-Rump Length (CRL). * **Best USG parameter for fetal growth (3rd Trimester):** Abdominal Circumference (AC). * **Ponderal Index:** Used to differentiate between symmetric and asymmetric FGR. * **Head Circumference/Abdominal Circumference (HC/AC) Ratio:** Increased in asymmetric FGR (brain-sparing effect).

Q: A female has a history of 6 weeks amenorrhea. Ultrasound shows an empty sac and serum p-hCG is 6500 IU/L. What would be the next management step?

Medical management. This question tests the concept of the **Discriminatory Zone** in early pregnancy management. ### **Explanation of the Correct Answer** The **Discriminatory Zone** is the level of serum β-hCG above which an intrauterine gestational sac should be visible on ultrasound. For Transvaginal Sonography (TVS), this threshold is typically **1,500–2,000 IU/L**. In this patient, the β-hCG is **6,500 IU/L**, which is significantly above the discriminatory zone. The presence of an **empty sac** (gestational sac without a yolk sac or embryo) at this hCG level, combined with 6 weeks of amenorrhea, confirms a **failed early pregnancy** (Anembryonic pregnancy/Blighted ovum). Once a non-viable pregnancy is diagnosed, the next step is termination. **Medical management** (using Misoprostol with or without Mifepristone) is the preferred first-line approach for a stable patient. ### **Why Other Options are Incorrect** * **B & C (Repeat hCG):** Serial β-hCG monitoring is indicated in "Pregnancy of Unknown Location" (PUL), where the hCG is *below* the discriminatory zone and no sac is seen. Here, the level is high and a sac is visible, making the diagnosis of failure certain. Delaying treatment increases the risk of hemorrhage. * **D (Surgical management):** While an option for failed pregnancies (D&C or MVA), medical management is generally preferred as the initial step unless the patient is hemodynamically unstable or has contraindications to drugs. ### **High-Yield Clinical Pearls for NEET-PG** * **Discriminatory Zone (TVS):** 1,500–2,000 IU/L. * **Discriminatory Zone (TAS):** 6,000–6,500 IU/L. * **Diagnosis of Blighted Ovum (SRU Criteria):** Mean Sac Diameter (MSD) of **≥25 mm** with no embryo on TVS. * **Normal hCG Doubling Time:** In a viable pregnancy, β-hCG levels should increase by at least 35–53% every 48 hours. * **Yolk Sac Appearance:** Should be seen via TVS when MSD is **8 mm**.

Q: All of the following antenatal screening tools indicate increased risk of Down syndrome EXCEPT?

Decreased nuchal fold thickness. **Explanation:** The correct answer is **A. Decreased nuchal fold thickness**. In Down syndrome (Trisomy 21), the characteristic finding is an **increased** nuchal fold thickness (measured in the second trimester) or increased nuchal translucency (measured in the first trimester), not a decrease. **Analysis of Options:** * **A. Decreased nuchal fold thickness:** This is the correct "Except" choice. A nuchal fold ≥ 6 mm between 15–20 weeks of gestation is a significant soft marker for Down syndrome. * **B. Increased Inhibin level:** In the second-trimester **Quadruple Screen**, both **Inhibin-A** and **hCG** are **elevated** ("HI" up), while AFP and unconjugated estriol (uE3) are decreased. * **C. Absence of nasal bone:** Hypoplasia or absence of the nasal bone during the 11–14 week ultrasound is a highly specific first-trimester marker for Down syndrome. * **D. Decreased PAPP-A level:** In the first-trimester screening, low levels of Pregnancy-Associated Plasma Protein-A (PAPP-A) combined with high free β-hCG are indicative of Trisomy 21. **High-Yield Clinical Pearls for NEET-PG:** * **First Trimester Screen (11–14 weeks):** Increased Nuchal Translucency (NT), low PAPP-A, and high β-hCG. * **Quadruple Screen (15–20 weeks):** * **Mnemonic "HI":** **H**CG and **I**nhibin-A are **High**. * **AFP and uE3:** Both are **Low**. * **Most sensitive USG marker:** Increased Nuchal Translucency (1st trimester) and Nuchal Fold (2nd trimester). * **Commonest Cardiac Anomaly:** Endocardial cushion defect (AV canal defect).

Q: A 30-year-old G1P0 woman complains of nausea and vomiting for the first 3 months of her pregnancy. She is noted to have a hemoglobin level of 9.0 g/dl and a mean corpuscular volume of 110 fL (normal 90-105 fL). Which of the following is the most likely etiology of the anemia?

Folate deficiency. **Explanation:** The patient presents with **macrocytic anemia** (Hemoglobin 9.0 g/dL, MCV 110 fL) in the first trimester of pregnancy, complicated by nausea and vomiting. **1. Why Folate Deficiency is correct:** Folate deficiency is the **most common cause of megaloblastic anemia** during pregnancy. Pregnancy increases folate requirements five-fold to support rapid fetal growth and placental development. In this case, the patient’s persistent nausea and vomiting (likely *Hyperemesis Gravidarum*) further deplete folate stores due to poor oral intake and malabsorption. Unlike Vitamin B12, folate stores in the body are limited (lasting only 3–4 months), making deficiency manifest quickly under physiological stress. **2. Why the other options are incorrect:** * **Iron Deficiency:** This is the most common cause of anemia in pregnancy overall, but it typically presents as **microcytic hypochromic** anemia (low MCV). * **Vitamin B12 Deficiency:** While it also causes macrocytic anemia, it is rare in pregnancy because B12 stores are vast (lasting 3–5 years) and are usually only depleted in strict vegans or patients with gastric bypass/pernicious anemia. * **Physiologic Anemia:** This occurs due to a disproportionate increase in plasma volume compared to red cell mass. However, it is a **normocytic** anemia (normal MCV) and usually manifests more significantly in the second trimester. **Clinical Pearls for NEET-PG:** * **MCV >100 fL** in pregnancy should always trigger a workup for Megaloblastic Anemia. * **Peripheral Smear:** Look for hypersegmented neutrophils (earliest sign). * **Prophylaxis:** The WHO recommends **400 µg (0.4 mg)** of folic acid daily for all pregnant women to prevent Neural Tube Defects (NTDs). * **High-risk dose:** Women with a previous child with NTD or those on anti-epileptics require **4 mg** daily.

Question 1

What is the best marker for gestational age in the second trimester?

Accepted Answer

Biparietal diameter

Answer

Head circumference

Answer

Crown-rump length (CRL)

Answer

Femur length

Question 2

Which is the least likely physiological change in pregnancy?

Accepted Answer

Increase in peripheral vascular resistance

Answer

Increase in intravascular volume

Answer

Increase in cardiac output

Answer

Increase in stroke volume

Question 3

At what gestational age is the yolk sac earliest seen?

Accepted Answer

5.5 weeks

Answer

7.5 weeks

Answer

10 weeks

Answer

12.5 weeks

Question 4

Which of the following conditions is associated with increased AFP levels?

Accepted Answer

Congenital nephrosis

Answer

Down's syndrome

Answer

Molar pregnancy

Answer

Overestimated gestational age

Question 5

What is the definition of full-term pregnancy in terms of gestational weeks?

Accepted Answer

39 completed to 40 6/7 weeks

Answer

37 completed to 38 6/7 weeks

Answer

41 completed to 41 6/7 weeks

Answer

42 completed weeks

Question 6

Which of the following is NOT a criterion for fetal growth assessment?

Accepted Answer

Maternal weight gain

Answer

Height of the uterus

Answer

Ultrasonographic measurement of biparietal diameter

Answer

Ultrasonographic measurement of fetal abdominal circumference

Question 7

A female has a history of 6 weeks amenorrhea. Ultrasound shows an empty sac and serum p-hCG is 6500 IU/L. What would be the next management step?

Accepted Answer

Medical management

Answer

Repeat hCG after 48 hours

Answer

Repeat hCG after 1 week

Answer

Surgical management

Question 8

All of the following antenatal screening tools indicate increased risk of Down syndrome EXCEPT?

Accepted Answer

Decreased nuchal fold thickness

Answer

Increased Inhibin level

Answer

Absence of nasal bone

Answer

Decreased PAPP-A level

Question 9

A 37-year-old primigravida, Rh-negative patient at 16 weeks gestation is concerned about her pregnancy due to her age. She is HIV negative, hepatitis B surface antigen negative, Rubella nonimmune, and asymptomatic. Her triple test results are normal. Despite this, she insists on undergoing amniocentesis due to her age. What is the next best step in management?

Accepted Answer

Advise against amniocentesis as it could increase the risk of isoimmunization.

Answer

Carefully follow Rh antibody titers and administer Anti-D immunoglobulin if evidence of isoimmunization is present.

Answer

Administer Anti-D immunoglobulin at 28 weeks of gestation and after delivery if the baby is Rh-negative.

Answer

Administer Anti-D immunoglobulin prior to her amniocentesis.

Question 10

A 30-year-old G1P0 woman complains of nausea and vomiting for the first 3 months of her pregnancy. She is noted to have a hemoglobin level of 9.0 g/dl and a mean corpuscular volume of 110 fL (normal 90-105 fL). Which of the following is the most likely etiology of the anemia?

Accepted Answer

Folate deficiency

Answer

Iron deficiency

Answer

Vitamin B12 deficiency

Answer

Physiologic anemia of pregnancy

Prenatal Care — MCQs

Prenatal Care — MCQs

On this page

Practice by Chapter

Want unlimited practice?